MCIA and AMCA – A Unified Voice for the Medicinal Cannabis Industry

Joint Media Release for Cannabiz

The two leading industry associations in the medicinal cannabis sector, Australian Medicinal Cannabis Association (AMCA) and Medicinal Cannabis Industry Association (MCIA) are delighted to announce their intention to collaborate more closely for the benefit of their members and the medicinal cannabis sector as a whole and to facilitate interactions with government bodies and other stakeholders as one unified voice.

Dr. Teresa Nicoletti, Chair of AMCA commented “For many years, MCIA and AMCA have been interacting separately with the Federal, State or Territory and local governments and their Departments and advisory bodies, as well as other organisations such as the Parliamentary Friends of Medicinal Cannabis (PFMC). As our organisations’ outlooks have become more aligned, and through a series of recent meetings, we agree that working together would be more productive for us, our members and the wider sector, and easier for so many of the third parties with whom both of our organisations interact”.

Peter Koetsier, Chair of MCIA, added: ‘Supporting the breadth of the Australian medicinal cannabis sector whilst enhancing patient wellbeing through facilitating patient access to quality medicinal cannabis product is important to both MCIA and AMCA. Working collaboratively for the sector will resonate more loudly than individual voices.’

Ends

MEDIA CONTACTS

Patty Holmes
Executive Officer, MCIA
0408 200 938

About MCIA:

MCIA is the peak industry body and voice for Australia’s medicinal cannabis industry. Our focus is on building a legitimate industry that enhances wellbeing through facilitating access to quality Australian medicinal cannabis products for Australian and global patients. MCIA provides stewardship for an economically sustainable and socially responsible industry that is trusted and valued by patients, the medical community and governments. The Australian industry and its products are built on sound science and underpinned by industry processes and standards that ensure patients, the medical community and governments have confidence in the sector and its products.

About ACannabis:

ACannabis Conference and Exhibition is hosted annually by MCIA. Covering cultivation, manufacturing, products and patients, the conference will examine innovations in research, compliance, regulations, education, and technology. ACannabis brings together participants from across the medicinal cannabis ecosystem, including policy makers, regulators, researchers, global leaders, healthcare professionals, patients and industry participants. Registrations at www.acannabis.com.au

MCIA Announces New Chair

Medicinal Cannabis Industry Australia (MCIA) has announced Peter Crock will step down as Chair, with Director Peter Koetsier appointed in his place effective immediately.

Speaking at MCIA’s AGM on Wednesday, Mr Crock confirmed he will remain on the board as a director to ensure a smooth transition and support the new chair.

Mr Koetsier is the Chief Executive Officer of Cann Group Limited, Australia’s first commercially licensed medicinal cannabis cultivator and manufacturer, having taken over the role from Mr Crock in January this year.

Mr Koetsier boasts more than 30 years of general management, marketing and commercial leadership roles within global pharmaceutical companies and has held leadership positions on industry representative boards previously.

Mr Crock said, “After seven long years in the pressure cooker of a nascent industry, I have decided it is the right time for me to hand the baton on. It has been an honour and a privilege to be at the forefront of such an important opportunity, to break the shackles and stigma of prohibition, and provide all important access to effectively a new class of compound to medicine in Australia and around the world.”

Mr Koetsier added, “It is an honour and a privilege to accept this role to represent the MCIA member companies. I’d like to acknowledge the valuable role Peter Crock has played in guiding this industry through its early years. Peter’s work to develop strong industry relationships with government representatives and departments has allowed MCIA to have a strong voice for change. He has led MCIA through a time of unprecedented growth in patient access and acceptance of our industry. I look forward to continuing the work to facilitate the growth, development and reputation of the medicinal cannabis industry.”

Download this Media Release .PDF

MEDIA CONTACTS

Patty Holmes
Executive Officer, MCIA
0408 200 938

About MCIA:

MCIA is the peak industry body and voice for Australia’s medicinal cannabis industry. Our focus is on building a legitimate industry that enhances wellbeing through facilitating access to quality Australian medicinal cannabis products for Australian and global patients. MCIA provides stewardship for an economically sustainable and socially responsible industry that is trusted and valued by patients, the medical community and governments. The Australian industry and its products are built on sound science and underpinned by industry processes and standards that ensure patients, the medical community and governments have confidence in the sector and its products.

About ACannabis:

ACannabis Conference and Exhibition is hosted annually by MCIA. Covering cultivation, manufacturing, products and patients, the conference will examine innovations in research, compliance, regulations, education, and technology. ACannabis brings together participants from across the medicinal cannabis ecosystem, including policy makers, regulators, researchers, global leaders, healthcare professionals, patients and industry participants. Registrations at www.acannabis.com.au

MCIA welcomes ATMAC grant to boost medicinal cannabis exports

In a first for the medicinal cannabis industry, Medicinal Cannabis Industry Australia (MCIA), the peak body for Australia’s medicinal cannabis industry, has been awarded a $250,000 Agricultural Trade and Market Access Cooperation (ATMAC) grant to assist Australian medicinal cannabis companies in securing global markets for medicinal cannabis products.

Continue reading “MCIA welcomes ATMAC grant to boost medicinal cannabis exports”

MCIA launches Olivia Newton-John Service to Industry Award to recognise excellence in the medicinal cannabis industry

“The Medicinal Cannabis Industry Australia is pleased and excited to launch the Olivia Newton-John Service to Industry award”, said Mr Peter Crock, MCIA Chair, “and we are particularly honoured to have Olivia’s husband Mr John Easterling with us at ACannabis to formerly open the call for nominations for the inaugural 2023 Service to Industry Award”.

Continue reading “MCIA launches Olivia Newton-John Service to Industry Award to recognise excellence in the medicinal cannabis industry”

MCIA and Epilepsy Action Australia partner to deliver independent information for the medicinal cannabis industry

Medicinal Cannabis Industry Australia (MCIA) is the voice for Australia’s medicinal cannabis industry and is focused on representing the mutual interests of members to build a sustainable and responsible industry that is trusted, valued, puts patients first and recognised for its quality and innovation.

Epilepsy Action Australia (EAA) as the leading and oldest provider of epilepsy services nationwide, focuses on improving self-management skills, increasing wider public understanding of this devastating condition, and are at the forefront of partnering and funding research into interventions and treatments. EAA also operate CanGuide, an independent and impartial service providing information on cannabis-based medicine.

Continue reading “MCIA and Epilepsy Action Australia partner to deliver independent information for the medicinal cannabis industry”

MCIA investigations shine further light on Australia’s medicinal cannabis industry

In October MCIA released data obtained from the Office of Drug Control that revealed the volume of medicinal cannabis produced by Australian cultivators, along with volumes of imports and exports. MCIA has now obtained data from TGA that sheds light on the nature of products sold in Australia.

Continue reading “MCIA investigations shine further light on Australia’s medicinal cannabis industry”